Literature DB >> 16111730

Toxoplasmic meningoencephalitis in an immunocompetent host.

Rajeev M Kaushik1, Sukhdev K Mahajan, Anita Sharma, Reshma Kaushik, Ranjan Kukreti.   

Abstract

Central nervous system involvement due to toxoplasmosis in an immunocompetent host is very rare. We report a case of an immunocompetent patient who presented with suspected tuberculous meningoencephalitis but showed no clinical response to antitubercular therapy. Later, toxoplasmic meningoencephalitis was proved by positive serological testing for toxoplasmosis, supportive magnetic resonance imaging findings of the brain and a therapeutic response to co-trimoxazole and prednisolone. Therefore, toxoplasmosis should be considered in cases of suspected tuberculous meningoencephalitis that fail to respond to specific therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111730     DOI: 10.1016/j.trstmh.2005.06.017

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour.

Authors:  J P Webster; P H L Lamberton; C A Donnelly; E F Torrey
Journal:  Proc Biol Sci       Date:  2006-04-22       Impact factor: 5.349

2.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

3.  Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis.

Authors:  Mario Habek; David Ozretić; Kamelija Zarković; Visnja Djaković; Zdenko Mubrin
Journal:  Neurol Sci       Date:  2009-01-16       Impact factor: 3.307

4.  Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data.

Authors:  S Bernard; A Mailles; J P Stahl
Journal:  Epidemiol Infect       Date:  2012-11-21       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.